Full Text View
Tabular View
Study Results
Related Studies
A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee
This study has been completed.
First Received: January 10, 2007   Last Updated: October 28, 2009   History of Changes
Sponsor: Alpharma Inc.
Information provided by: Alpharma Inc.
ClinicalTrials.gov Identifier: NCT00420992
  Purpose

The purpose of this study is to evaluate the efficacy of Kadian NT (ALO-01) compared with placebo for treating moderate to severe chronic pain over a 12 week period.


Condition Intervention Phase
Osteoarthritis
Chronic Pain
Drug: ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER)
Drug: Placebo
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Efficacy Study
Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Efficacy Study of Kadian NT (Morphine Sulfate Plus Naltrexone Hydrochloride Extended-Release) Capsules in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Hip or Knee

Resource links provided by NLM:


Further study details as provided by Alpharma Inc.:

Primary Outcome Measures:
  • Mean Change in Diary Brief Pain Inventory Score of Average Pain (Daily Scores of Average Pain Averaged Over 7 Days) [ Time Frame: randomization to 12 weeks following randomization ] [ Designated as safety issue: No ]

Enrollment: 547
Study Start Date: December 2006
Study Completion Date: November 2007
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
ALO-01: Experimental Drug: ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER)
capsules, 20-160 mg total daily dose, given either once daily or twice daily
Placebo: Placebo Comparator Drug: Placebo
capsules

Detailed Description:

The primary objective of this study is to evaluate the efficacy of ALO-01 compared with placebo for the treatment of chronic moderate to severe pain (focusing on osteoarthritis of the hip or knee) as measured by mean change in diary BPI score of average pain (daily scores of average pain averaged over 7 days) from randomization to 12 weeks following randomization.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subject is 21 years of age or older
  • Subject is either not of childbearing potential OR subject must use an acceptable method of birth control if of childbearing potential
  • Negative pregnancy test if female of childbearing potential
  • Subject is in general good health
  • Subject required treatment of joint pain within the last 90 days
  • Subject has primary diagnosis of OA of the hip or knee

Exclusion Criteria:

  • Subject has a documented history of allergic reaction or intolerance to morphine or other opioids
  • Subject is pregnant or breast-feeding
  • Subject is receiving systemic chemotherapy
  • Subject has a history of drug abuse/dependence/misuse or alcohol abuse/dependence
  • Subject has history of major depressive disorder not controlled with medication
  • Subject has any chronic pain syndrome (i.e., fibromyalgia) that may interfere with the symptoms of OA
  • Subject has active gastrointestinal disease, with the exception of GERD
  • Subject has a documented history of rheumatoid arthritis, uncontrolled inflammatory arthritis or NSAID-dependent inflammatory arthritis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00420992

  Hide Study Locations
Locations
United States, Alabama
The Birmingham Pain Center
Birmingham, Alabama, United States, 35244
Horizon Research Group
Mobile, Alabama, United States, 36608
United States, Arizona
Arizona Research Center, Inc
Phoenix, Arizona, United States, 85023
Arizona Center for Clinical Research
Peoria, Arizona, United States, 85383
Premiere Pharmaceutical Research, LLC
Tempe, Arizona, United States, 85282
United States, California
Med Investigators Inc
Fair Oaks, California, United States, 95628
STAT-CARE / Crest Clinical Trials
Anaheim, California, United States, 92804
NervePro Research
Irvine, California, United States, 92618
Private Practice
Pico Rivera, California, United States, 90660
Boling Clinical Trials
Upland, California, United States, 91786
Southbay Pharma Research
Buena Park, California, United States, 90620
Advanced Clinical Research Institute
Anaheim, California, United States, 92801
Quality of Life Medical Center, LLC
Hawaiian Gardens, California, United States, 90716
Orange County Clinical Trials
Anaheim, California, United States, 92801
Providence Clinical Res. (C-trials)
Burbank, California, United States, 91505
UCSD Pain and Palliative Care
La Jolla, California, United States, 92093
USCD Pain and Palliative Care
La Jolla, California, United States, 92093
Pain Institute of Santa Monica
Santa Monica, California, United States, 90404
United States, Colorado
Mountain View Clinical Research, Inc
Denver, Colorado, United States, 80209
United States, Connecticut
New England Research Associates, LLC
Trumbull, Connecticut, United States, 06611
Stamford Therapeutics Consortium
Stamford, Connecticut, United States, 06905
United States, Florida
Florida Institute of Medical Research
Jacksonville, Florida, United States, 32257
University Clinical Research, Inc
Pembroke Pines, Florida, United States, 33024
Gold Coast Research LLC
Weston, Florida, United States, 33331
FPA Clinical Research
Kissimmee, Florida, United States, 34741
Innovative Research of West Florida
Largo, Florida, United States, 33770
Drug Study Institiute
Jupiter, Florida, United States, 33458
Ormond Medical Arts - Pharmaceutical Research Center
Ormond Beach, Florida, United States, 32174
Stedman Clinical Trials
Tampa, Florida, United States, 33613
Eastern Research
Hialeah, Florida, United States, 33013
Pharmaceutical Research Associates Inc
Merritt Island, Florida, United States, 32953
Coastal Medical Research
Port Orange, Florida, United States, 32127
MD Clinical
Hallandale Beach, Florida, United States, 33009
United States, Georgia
Best Clinical Research
Decatur, Georgia, United States, 30034
Drug Studies America
Marietta, Georgia, United States, 30066
River Birch Research Alliance
Blue Ridge, Georgia, United States, 30513
Non-Surgical Orthopaedic and Spine Center
Marietta, Georgia, United States, 30060
United States, Idaho
Northwest Clinical Trials
Boise, Idaho, United States, 83704
United States, Illinois
Research Associates of Central Illinois
Peoria, Illinois, United States, 61614
United States, Indiana
MediSphere Medical Research Center, LLC
Evansville, Indiana, United States, 47714
Welborn Clinic
Newburgh, Indiana, United States, 47630
United States, Kansas
International Clinical Research Institute, Inc
Overland Park, Kansas, United States, 66211
United States, Louisiana
Lousiana Research Associates Inc.
New Orleans, Louisiana, United States, 70114
Clinical Trials Management, LLC
Mandeville, Louisiana, United States, 70471
United States, Maryland
Internal Research Center
Towson, Maryland, United States, 21286
United States, Massachusetts
FutureCare Studies
Springfield, Massachusetts, United States, 01107
Northeast Medical Research Associates, Inc
No Dartmouth, Massachusetts, United States, 02747
Phase III Clinical Research
Fall River, Massachusetts, United States, 02720
United States, Michigan
Synergy Medical Education Alliance
Saginaw, Michigan, United States, 48602
United States, Missouri
Medex Healthcare Research Inc
St. Louis, Missouri, United States, 63117
United States, Nevada
Advanced Biomedical Research of America
Las Vegas, Nevada, United States, 89123
Lovelace Scientific
Henderson, Nevada, United States, 89014
United States, New Jersey
Partners in Primary Care
Voorhees, New Jersey, United States, 08043
United States, New York
Elkind Headache Center
Mount Vernon, New York, United States, 10550
United States, North Carolina
The Arthritis Clinic and Carolina Bone and Joint
Charlotte, North Carolina, United States, 28210
The Center for Clinical Research, LLC
Winston-Salem, North Carolina, United States, 27103
United States, Ohio
Community Research
Cincinnati, Ohio, United States, 45227
Clinical Research Source, Inc
Toledo, Ohio, United States, 43551
Community Research
Cincinnati, Ohio, United States, 45245
United States, Oklahoma
COR Clinical Research
Oklahoma City, Oklahoma, United States, 73103
Health Research Institute
Oklahoma City, Oklahoma, United States, 73109
Tulsa Clinical Research
Tulsa, Oklahoma, United States, 74101
Cutting Edge Research
Oklahoma City, Oklahoma, United States, 73116
United States, Pennsylvania
Commonwealth Primary Care / Fleetwood Clinical Research
Fleetwood, Pennsylvania, United States, 19522
Pivotal Clinical Research, LLC
Souderton, Pennsylvania, United States, 18964
Tipton Medical and Diagnostic Center
Tipton, Pennsylvania, United States, 16684
Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States, 16635
Pennsylvania Research Institute
Bensalem, Pennsylvania, United States, 19020
LVH Neurosciences and Pain Research
Allentown, Pennsylvania, United States, 18103
United States, Tennessee
Integrity Clinical Research, LLC
Milan, Tennessee, United States, 38358
Premier Medical Group
Clarksville, Tennessee, United States, 37043
Comprehensive Pain Specialists
Hendersonville, Tennessee, United States, 37075
SCRI
Cordova, Tennessee, United States, 38018
SCRI
Memphis, Tennessee, United States, 38119
United States, Texas
Radiant Research, San Antonio Northeast
San Antonio, Texas, United States, 78217
Walter F. Chase, MD, PA
Austin, Texas, United States, 78705
Progressive Clinical Research
San Antonio, Texas, United States, 78229
InSite Clinical Research
DeSoto, Texas, United States, 75115
Team Research of Central Texas
Killeen, Texas, United States, 76543
North San Antonio Healthcare Associates
San Antonio, Texas, United States, 78218
United States, Virginia
HypotheTest, LLC
Roanoke, Virginia, United States, 24018
Sponsors and Collaborators
Alpharma Inc.
Investigators
Study Director: James B. Jones, MD, PharmD Alpharma Pharmceuticals
  More Information

No publications provided

Responsible Party: King Pharmaceuticals Research and Development ( Kenneth Sommerville, M.D., FAAN, Vice President, Clinical Development )
Study ID Numbers: ALO-KNT-301
Study First Received: January 10, 2007
Results First Received: September 11, 2009
Last Updated: October 28, 2009
ClinicalTrials.gov Identifier: NCT00420992     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Alpharma Inc.:
hip
knee
pain
osteoarthritis
OA
Kadian
Alpharma
naltrexone
Opioid
morphine
Embeda
ALO-01

Additional relevant MeSH terms:
Morphine
Osteoarthritis
Joint Diseases
Narcotic Antagonists
Physiological Effects of Drugs
Central Nervous System Depressants
Narcotics
Osteoarthritis, Hip
Rheumatic Diseases
Pharmacologic Actions
Musculoskeletal Diseases
Sensory System Agents
Therapeutic Uses
Arthritis
Naltrexone
Analgesics
Peripheral Nervous System Agents
Central Nervous System Agents
Analgesics, Opioid

ClinicalTrials.gov processed this record on November 27, 2009